Latest Organofluorides Stories
ReportsnReports.com adds "Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023" to its store.
RnRMarketResearch.com adds “TS-1 (Colorectal Cancer) – Forecast and Market Analysis to 2023” to its store.
The Firm is actively filing Risperdal lawsuits in this proceeding on behalf of men and boys who allegedly developed gynecomastia due to its use. New York, New
DUBLIN, Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the Company has received a complete response letter from the U.S.
Study Seeks to Confirm a High Response Rate among Cancer Patients with MET and Axl Genetic Alterations SAN DIEGO, Dec. 23, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc.
The Firm is currently representing numerous men and boys in Risperdal lawsuits that also allege the drug caused gynecomastia, a condition marked by the excessive breast growth in male patients.
The Firm is representing numerous men and boys in Risperdal lawsuits, all of whom allegedly developed gynecomastia (male breast growth) due to an elevation of prolactin caused by Risperdal.
Publication of the study comes amid numerous Risperdal lawsuit filings that allege the medication caused gynecomastia in men and boys. New York, New York (PRWEB)
-- Novel irreversible pan-erbB inhibitor is active against patient-derived GBM xenografts overexpressing EGFR, including the disease-driving EGFRvIII mutation MENLO PARK, Calif., Dec.
BOTHELL, Wash. and VANCOUVER, British Columbia, Dec. 16, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc.
- A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.